Нүүр зураг

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

Abstract Background Observational studies are used to measure the effectiveness of an intervention in non-experimental, real world scenarios at the population level and are recognised as an important component of the evidence pyramid. Such data can be accrued through prospective cohort studies and a...

Бүрэн тодорхойлолт

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Emma Gray (Зохиогч), David J. Pasta (Зохиогч), Suzanne Norris (Зохиогч), Aisling O'Leary (Зохиогч), on behalf of the Irish Hepatitis C Outcomes and Research Network (ICORN) (Зохиогч)
Формат:	Ном
Хэвлэсэн:	BMC, 2017-04-01T00:00:00Z.
Нөхцлүүд:	article
Онлайн хандалт:	Connect to this object online.
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

A study on the prevalence of HCV genotypes and the effect of direct-acting antiviral therapy on clinical and laboratory parameters in HCV-Infected patients at a tertiary care center in North India
-н: S Muhammed Shahanas, зэрэг
Хэвлэсэн: (2024)

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
-н: Kimberly Struble, зэрэг
Хэвлэсэн: (2019)

Determination of HCV Genotypes in Iranian Isolates by PCR-RFLP
-н: MH Ahmadi Pour, зэрэг
Хэвлэсэн: (2006)

Genotyping Pattern Among Iranian HCV Positive Patients
-н: A Sarafnejad, зэрэг
Хэвлэсэн: (2010)

Genotyping Pattern among Iranian HCV Positive Patients
-н: M Hajia, зэрэг
Хэвлэсэн: (2010)

Determination of HCV Genotypes in Iranian Isolates by PCR-RFLP
-н: MH Ahmadi Pour, зэрэг
Хэвлэсэн: (2006)

Direct action antivirals are effective in the total eradication of HCV in renal transplants
-н: Teresa Olea, зэрэг
Хэвлэсэн: (2019)

Antiviral therapy of HCV-cirrhosis: case of sequential treatment and review of literature
-н: Kakharman Yesmembetov, зэрэг
Хэвлэсэн: (2018)

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
-н: K Samimi-rad, зэрэг
Хэвлэсэн: (2008)

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
-н: K Samimi-rad, зэрэг
Хэвлэсэн: (2008)

Understanding the factors influencing community pharmacist retention - A qualitative study
-н: Matthew Lynch, зэрэг
Хэвлэсэн: (2023)

Impact of HCV antiviral therapy on the Liver Transplantation Waiting-List assessed by mathematical models
-н: Eleazar Chaib, зэрэг
Хэвлэсэн: (2019)

SCORING MODELS FOR PREDICTING HEPATOCELLULAR CARCINOMA RISK IN HCV PATIENTS AFTER ANTIVIRAL THERAPY
-н: Oana Irina Gavril, зэрэг
Хэвлэсэн: (2023)

Identification of the Genotypes Circulating in the Ecuadorian Population Infected with the Hepatitis C Virus (HCV)
-н: Moncayo M, зэрэг
Хэвлэсэн: (2023)

P49 MAGELLAN-1, PART 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic HCV genotype 1 or 4 and prior direct-acting antiviral treatment failure
-н: Fred Poordad, зэрэг
Хэвлэсэн: (2017)

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
-н: Cristina Stasi, зэрэг
Хэвлэсэн: (2016)

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
-н: Nicola Imperatore, зэрэг
Хэвлэсэн: (2017)

Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
-н: Saima Mushtaq, зэрэг
Хэвлэсэн: (2022)

Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients
-н: Grenda Leite Pereira, зэрэг
Хэвлэсэн: (2019)

Prevalence of HCV infection and prevalent genotypes of HCV among drug users in Inner Mongolia Autonomous Region, 2022: a sentinel surveillance-based cross-sectional survey
-н: Huai ZHANG, зэрэг
Хэвлэсэн: (2024)

Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
-н: Ramy H. Agwa, зэрэг
Хэвлэсэн: (2022)

<it>PNPLA 3</it> I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
-н: Rembeck Karolina, зэрэг
Хэвлэсэн: (2012)

Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection
-н: M. Galeazzi, зэрэг
Хэвлэсэн: (2011)

Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world
-н: Sarah R. Donaldson, зэрэг
Хэвлэсэн: (2022)

An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs
-н: Adita Ayu Permanasari, зэрэг
Хэвлэсэн: (2021)

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease
-н: Mahim Khan, зэрэг
Хэвлэсэн: (2022)

Bridging the gap between healthcare professions' regulation and practice: the "lived experience" of community pharmacists in Ireland following regulatory change
-н: Matthew Lynch, зэрэг
Хэвлэсэн: (2022)

HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study
-н: Nesrin Dilbaz, зэрэг
Хэвлэсэн: (2023)

Binding of GS-461203 and Its Halogen Derivatives to HCV Genotype 2a RNA Polymerase Drug Resistance Mutants
-н: Muhammad Arba, зэрэг
Хэвлэсэн: (2022)

Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1 Patients Treated by Pegylated Interferon and Ribavirin
-н: Fahimeh Safarnezhad Tameshkel, зэрэг
Хэвлэсэн: (2016)

Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents
-н: Zhi Jiang, зэрэг
Хэвлэсэн: (2015)

Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
-н: Mario Enrico Canonico, зэрэг
Хэвлэсэн: (2022)

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
-н: Borba HHL, зэрэг
Хэвлэсэн: (2017)

The Clinical Implementation of Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry
-н: Jaouad Azzahhafi MD, зэрэг
Хэвлэсэн: (2023)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
-н: Polilli E, зэрэг
Хэвлэсэн: (2016)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.
-н: Sudhamshu Kc, зэрэг
Хэвлэсэн: (2020)

Neurodevelopmental outcomes of very low birth weight infants in the Neonatal Research Network of Japan: importance of neonatal intensive care unit graduate follow-up
-н: Yumi Kono, зэрэг
Хэвлэсэн: (2021)

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir in Treating HCV Genotypes 1 and 4 in Patients with Advanced Chronic Kidney Disease
-н: Badr M. Aljarallah
Хэвлэсэн: (2024)

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4
-н: Olfat Shaker, зэрэг
Хэвлэсэн: (2013)

The protective effect of helmet use in motorcycle and bicycle accidents: a propensity score-matched study based on a trauma registry system
-н: Spencer C. H. Kuo, зэрэг
Хэвлэсэн: (2017)